Fluticasone Propionate
Product Images NDC 53002-2294

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Fluticasone Propionate (NDC 53002-2294). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fluticasone Propionate Chemical Structure (Fluticasonepropionatehfa Spl Graphic 01)

Chemical structure diagram of fluticasone propionate, displaying its molecular composition with various carbon rings, fluorine, hydroxyl, and other functional groups as typically represented in organic chemistry.*

FDA Label Image

Figure 1. A 12-week Clinical Trial In Subjects Aged 12 Years And Older Inadequately Controlled On Bronchodilators Alone: Mean Percent Change From Baseline In Fev1 Prior To Am Dose (trial 1) (Fluticasonepropionatehfa Spl Graphic 02)

A line graph showing percent change from baseline in FEV1 over time (weeks) for Fluticasone Propionate HFA 88 mcg twice daily compared to placebo. The graph depicts greater improvement in FEV1 with Fluticasone Propionate HFA versus placebo across the 12-week period and at the study endpoint.*

FDA Label Image

Figure 2. A 12-week Clinical Trial In Subjects Aged 12 Years And Older Already Receiving Daily Inhaled Corticosteroids: Mean Percent Change From Baseline In Fev1 Prior To Am Dose (trial 2) (Fluticasonepropionatehfa Spl Graphic 03)

A line graph depicting the percentage change from baseline in FEV1 over 12 weeks for four groups: Placebo, Fluticasone Propionate HFA 88 mcg twice daily, 220 mcg twice daily, and 440 mcg twice daily. The x-axis shows weeks from 0 to 12 and the endpoint, while the y-axis shows percentage change from baseline in FEV1 ranging from -12 to 14. The graph shows increasing FEV1 improvements over time for the fluticasone groups, with the highest dose yielding the greatest change.*

FDA Label Image

Figure 3. A 16-week Clinical Trial In Subjects Aged 12 Years And Older Requiring Chronic Oral Prednisone Therapy: Change In Maintenance Prednisone Dose (Fluticasonepropionatehfa Spl Graphic 04)

A bar chart depicting percentage of subjects achieving 100% reduction in dose and percentage experiencing dose increase. Data compares placebo, Fluticasone Propionate HFA 440 mcg twice daily, and 880 mcg twice daily groups. Labels indicate percentage values for each group.*

FDA Label Image

Figure A (Fluticasonepropionatehfa Spl Graphic 05)

Illustration of a Fluticasone Propionate HFA inhaler parts, showing a metal canister with a counter, dark orange plastic actuator and mouthpiece, and a separate peach-colored cap.*

FDA Label Image

Figure B (Fluticasonepropionatehfa Spl Graphic 06)

An instructional illustration showing two hands preparing an inhaler device. One hand holds the inhaler while the other hand removes or attaches a cap or cover from the mouthpiece, indicated by a left-pointing arrow.*

FDA Label Image

Figure C (Fluticasonepropionatehfa Spl Graphic 07)

An instructional illustration showing a hand holding a Fluticasone Propionate HFA inhaler, with an arrow indicating to spray the medication towards the mouth. The image depicts the inhaler releasing a spray as it is used.*

FDA Label Image

Figure D (Fluticasonepropionatehfa Spl Graphic 08)

An instructional diagram showing a hand holding a Fluticasone Propionate HFA inhaler with a label indicating '120'. The illustration likely demonstrates the proper way to hold and use the inhaler device for administration.*

FDA Label Image

Figure E (Fluticasonepropionatehfa Spl Graphic 09)

Illustration showing the proper usage of Fluticasone Propionate HFA inhaler with the mouthpiece in a down position. The image highlights the dark orange mouthpiece and peach-colored cap, with a hand holding the inhaler ready for use.*

FDA Label Image

Figure F (Fluticasonepropionatehfa Spl Graphic 10)

Illustration showing a side view of a person's face exhaling with the instruction to "Breathe out as much air as you can," indicated by dashed arrows moving outward from the mouth. This diagram is likely part of usage instructions for Fluticasone Propionate HFA inhaler.*

FDA Label Image

Figure G (Fluticasonepropionatehfa Spl Graphic 11)

An instructional illustration showing a person using a metered-dose inhaler. The person holds the inhaler vertically near the mouth and is instructed to push down on the canister while breathing in through the mouth.*

FDA Label Image

Figure H (Fluticasonepropionatehfa Spl Graphic 12)

An instructional illustration showing a person rinsing their mouth and spitting into a sink. A glass of water is placed nearby on the sink's edge. This image likely demonstrates proper post-inhalation care associated with using inhaled medication.*

FDA Label Image

Figure I (Fluticasonepropionatehfa Spl Graphic 13)

An instructional diagram showing two panels labeled 'Not blocked' and 'Blocked.' Both panels depict a nasal spray device; the 'Not blocked' panel illustrates proper spray release, while the 'Blocked' panel shows an obstructed spray path. This visual aids correct usage of the Fluticasone Propionate HFA nasal spray device.*

FDA Label Image

Figure J (Fluticasonepropionatehfa Spl Graphic 14)

An instructional illustration showing a hand positioning a cap over the mouthpiece of an inhaler device. The image depicts the motion of closing or securing the cap by pressing it down and rotating it into place.*

FDA Label Image

Label Image (Lbl530022294)

Fluticasone Propionate HFA 44MCG inhalation aerosol label for a 10.6 gram bottle by RPK Pharmaceuticals, Inc. The label includes directions to use the inhaler twice a day or as directed and contains spaces for clinic name, patient information, and prescription details. Various regulatory and billing codes are also printed on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.